Company profile for Asterias Biotherapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Asterias Biotherapeutics is a biotechnology company pioneering the field of regenerative medicine. We even draw our name from the common starfish, Asterias rubens, which has the ability to regenerate lost limbs even in adulthood. We are focused on employing our pluripotent stem cell and cancer immunotherapy platforms to develop therapeutics addressing significant unmet medical needs in neurology and oncology. These clinical-st...
Asterias Biotherapeutics is a biotechnology company pioneering the field of regenerative medicine. We even draw our name from the common starfish, Asterias rubens, which has the ability to regenerate lost limbs even in adulthood. We are focused on employing our pluripotent stem cell and cancer immunotherapy platforms to develop therapeutics addressing significant unmet medical needs in neurology and oncology. These clinical-stage programs are supported by robust proof-of-concept pre-clinical and clinical data. Our three clinical-stage programs include:

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
6300 Dumbarton Circle, Fremont, CA 94555
Telephone
Telephone
(510) 456-3800
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Lineage Cell Therapeutics, Asterias Investors Propose Settlement 
Lineage Cell Therapeutics, Asterias Investors Propose Settlement 

29 Oct 2022

// Lineage Cell Therapeutics BLOOMBERGLAW

https://news.bloomberglaw.com/health-law-and-business/lineage-cell-therapeutics-asterias-investors-propose-settlement

Lineage Cell Therapeutics BLOOMBERGLAW
29 Oct 2022
Fujifilm plans U.S. facility for stem cell treatments
Fujifilm plans U.S. facility for stem cell treatments

04 Jan 2019

// Eric Palmer FIERCE PHARMA

https://www.fiercepharma.com/pharma-asia/fujifilm-plans-20m-u-s-facility-for-burgeoning-interest-stem-cell-treatments

Eric Palmer FIERCE PHARMA
04 Jan 2019

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty